BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$716M |
| 2 |
Apple
AAPL
|
+$677M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$561M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$554M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.85B |
| 2 |
Equinix
EQIX
|
+$2.31B |
| 3 |
Tesla
TSLA
|
+$2.3B |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$1.87B |
| 5 |
TRLA
TRULIA INC (DEL)
TRLA
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.8% |
| 2 | Financials | 3.08% |
| 3 | Industrials | 1.77% |
| 4 | Healthcare | 1.71% |
| 5 | Materials | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ULTI
2401
DELISTED
Ultimate Software Group Inc
ULTI
| $6.49K | ﹤0.01% |
47
+5
| +12% | +$636 |
|
2402
Omeros
OMER
$1.26B
| $6.49K | ﹤0.01% |
373
+68
| +22% | +$858 |
|
2403
Tyler Technologies
TYL
$13.4B
| $6.48K | ﹤0.01% |
+71
| New | +$5.76K |
|
|
VRNT
2404
DELISTED
Verint Systems
VRNT
| $6.47K | ﹤0.01% |
+259
| New | +$6.09K |
|
|
IXYS
2405
DELISTED
IXYS Corp
IXYS
| $6.44K | ﹤0.01% |
523
+205
| +64% | +$2.27K |
|
2406
Pure Cycle
PCYO
$274M
| $6.38K | ﹤0.01% |
943
+215
| +30% | +$1.23K |
|
2407
MarketAxess Holdings
MKTX
$5.72B
| $6.38K | ﹤0.01% |
118
-39
| -25% | -$2.13K |
|
2408
TG Therapeutics
TGTX
$7.39B
| $6.35K | ﹤0.01% |
676
+78
| +13% | +$499 |
|
|
ASPX
2409
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $6.35K | ﹤0.01% |
+285
| New | +$6.24K |
|
|
MBFI
2410
DELISTED
MB Financial Corp
MBFI
| $6.33K | ﹤0.01% |
234
+118
| +102% | +$3.3K |
|
2411
AtriCure
ATRC
$2.21B
| $6.32K | ﹤0.01% |
344
+213
| +163% | +$3.54K |
|
|
POLY
2412
DELISTED
Plantronics, Inc.
POLY
| $6.29K | ﹤0.01% |
131
-2,265
| -95% | -$101K |
|
|
ELLI
2413
DELISTED
Ellie Mae Inc
ELLI
| $6.29K | ﹤0.01% |
+202
| New | +$5.42K |
|
|
ALX
2414
Alexander's
ALX
$1.4B
| $6.28K | ﹤0.01% |
17
-487
| -97% | -$175K |
|
|
ALE
2415
DELISTED
Allete
ALE
| $6.21K | ﹤0.01% |
121
+101
| +505% | +$5.08K |
|
2416
ProShares Ultra Energy
DIG
$86.2M
| $6.18K | ﹤0.01% |
56
+32
| +133% | +$3.17K |
|
|
LNCE
2417
DELISTED
Snyders-Lance, Inc.
LNCE
| $6.17K | ﹤0.01% |
233
+128
| +122% | +$3.45K |
|
2418
Mercury Insurance
MCY
$5.82B
| $6.16K | ﹤0.01% |
131
-11,689
| -99% | -$549K |
|
2419
H.B. Fuller
FUL
$3.29B
| $6.16K | ﹤0.01% |
128
-155
| -55% | -$7.42K |
|
2420
Ameris Bancorp
ABCB
$6.04B
| $6.14K | ﹤0.01% |
285
+230
| +418% | +$4.96K |
|
2421
Wolverine World Wide
WWW
$1.71B
| $6.12K | ﹤0.01% |
+235
| New | +$6.25K |
|
|
AMWD
2422
DELISTED
American Woodmark
AMWD
| $6.12K | ﹤0.01% |
192
+145
| +309% | +$4.43K |
|
|
HAWK
2423
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $6.1K | ﹤0.01% |
+216
| New | +$5.36K |
|
2424
TTEC Holdings
TTEC
$81.3M
| $6.09K | ﹤0.01% |
+210
| New | +$5.43K |
|
|
LUMO
2425
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $6.08K | ﹤0.01% |
+25
| New | +$5.08K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2014 Portfolio in Review
As of Q2 2014, BNP Paribas Financial Markets held 4,108 positions worth $106B, down 17% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets deployed $44.2B of net new capital in Q2 2014, opening 765 new positions and adding to 1,315 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 26% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $3.85B trimmed.
- BNP Paribas Financial Markets's largest Q2 2014 buy was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
- BNP Paribas Financial Markets added most to Potash Corp Of Saskatchewan in Q2 2014, an estimated $716M increase.
- BNP Paribas Financial Markets's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $3.85B.
- BNP Paribas Financial Markets fully exited Walter Investment Mgt Corp in Q2 2014, selling an estimated $477M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $106B portfolio in Q2 2014.
- BNP Paribas Financial Markets opened 765 new positions and closed 285 in Q2 2014.
- BNP Paribas Financial Markets's portfolio value fell 17% quarter-over-quarter to $106B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.